Pexelizumab -- a C5 complement inhibitor for use in both acute myocardial infarction and cardiac surgery with cardiopulmonary bypass. (Q53671152)
Jump to navigation
Jump to search
scientific article published in June 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pexelizumab -- a C5 complement inhibitor for use in both acute myocardial infarction and cardiac surgery with cardiopulmonary bypass. |
scientific article published in June 2005 |
Statements
Pexelizumab -- a C5 complement inhibitor for use in both acute myocardial infarction and cardiac surgery with cardiopulmonary bypass. (English)
1 reference
Ani J Fleisig
1 reference
Edward D Verrier
1 reference
1 June 2005
1 reference
5
1 reference
6
1 reference
833-839
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference